(Q46738962)

24 December 2017

title

Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung (English)

1 reference

24 December 2017

large cell neuroendocrine carcinoma of the lung

main subject

0 references

author name string

Antonio Marchetti

1

1 reference

24 December 2017

Lara Felicioni

2

1 reference

24 December 2017

Giuseppe Pelosi

3

1 reference

24 December 2017

Maela Del Grammastro

4

1 reference

24 December 2017

Caterina Fumagalli

5

1 reference

24 December 2017

Mariagrazia Sciarrotta

6

1 reference

24 December 2017

Sara Malatesta

7

1 reference

24 December 2017

Antonio Chella

8

1 reference

24 December 2017

Fabio Barassi

9

1 reference

24 December 2017

Felice Mucilli

10

1 reference

24 December 2017

Pierpaolo Camplese

11

1 reference

24 December 2017

Tommaso D'Antuono

12

1 reference

24 December 2017

Rocco Sacco

13

1 reference

24 December 2017

Fiamma Buttitta

14

1 reference

24 December 2017

publication date

1 May 2008

1 reference

24 December 2017

published in

Human Mutation

1 reference

24 December 2017

volume

29

1 reference

24 December 2017

page(s)

609-616

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

Neurotrophin signaling: many exciting surprises!

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Neuroendocrine neoplasms of the lung: a prognostic spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

The Trk family of neurotrophin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Mutational analysis of the tyrosine kinome in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

The new World Health Organization classification of lung tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

CEP-751 inhibits TRK receptor tyrosine kinase activity in vitro exhibits anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

The neurotrophic receptor TrkB: a drug target in anti-cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Large-cell neuroendocrine carcinoma of the lung: an aggressive neuroendocrine lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

The nerve growth factor family of receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

The neurotrophins NT3 and BDNF induce selective specification of neuropeptide coexpression and neuronal connectivity in arcuate and periventricular hypothalamic neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Neurotrophins and neurotrophin receptors in human lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Lung cancer: intragenic ERBB2 kinase mutations in tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Optimizing first-line treatment options for patients with advanced NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Rational basis for Trk inhibition therapy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

Somatic mutations of the protein kinase gene family in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

7 January 2021

Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

7 January 2021

Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

7 January 2021

Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

7 January 2021

Neurotrophin system expression in human pulmonary carcinoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

7 January 2021

Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20707

7 January 2021

Identifiers

DOI

10.1002/HUMU.20707

1 reference

24 December 2017

PubMed ID

18293376

1 reference

24 December 2017